Feifei Tang

12PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersHaematological tumoursBiomaterialsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 22, 2026
Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP -inf mutations: Insights from a multicentre Chinese cohort study.

|Mar 12, 2026
Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale Cohort.

Yijing Zhao, Ting Zhao, Feifei Tang

|Dec 01, 2025
Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insights.

Lin-Ya Wang, Hai-Tao Gao, Qiang Fu

|Aug 14, 2025
IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame Mutations.

Shunjie Yu, Lijuan Hu, Yazhen Qin

|Jul 12, 2025
KDM6A Variants Increased Relapse Risk in Adult Acute Myeloid Leukemia.

Yijing Zhao, Liting Niu, Sen Yang

|Feb 26, 2025
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese Patients.

Linya Wang, Haitao Gao, Qiang Fu

Pageof 2

Frequent Collaborators

7 joint publications

Qian Jiang

5 joint publications

Xiaojun Huang

4 joint publications

Yu Wang

3 joint publications

Hao Jiang